Facial Onset Sensory and Motor Neuronopathy: A Case Series and Literature Review

dc.contributor.author

Morena, Jonathan

dc.contributor.author

Kamdar, Hera

dc.contributor.author

Yasin, Rabia

dc.contributor.author

Hoyle, J Chad

dc.contributor.author

Quick, Adam

dc.contributor.author

Kolb, Stephen

dc.date.accessioned

2023-07-19T00:29:45Z

dc.date.available

2023-07-19T00:29:45Z

dc.date.updated

2023-07-19T00:29:44Z

dc.description.abstract

<jats:p>Introduction: Facial Onset Sensory and Motor Neuronopathy (FOSMN) typically presents with paresthesias in the trigeminal nerve distribution and weakness that progresses rostro-caudally. Objective: To present two new cases of FOSMN, summarize the current literature, and address areas for future study. Methods: Observational data was collected from two patients with FOSMN from our institution. A literature review of FOSMN was completed using PubMed. Results: We identified 100 cases of FOSMN, including our two new cases. 93% presented with facial paresthesias. 97% had bulbar symptoms. Five had family history of ALS. Abnormal Blink reflex was most common on EMG/NCS. CSF was typically normal, but a rare severe case showed elevated protein. Mutations included: TARDBP, OPMD, D90A-SOD1, CHCHD10, VCP, and SQSTM1. Neuropathological studies showed neurodegenerative changes without inflammation. Some cases have reported transient stabilization or improvement to immunomodulatory therapy. Case Reports: A 72-year-old man presented with right-sided trigeminal paresthesias that progressed in a rostro-caudal fashion, dysphagia, and hand weakness. He died 4-5 years after symptom onset. A 69-year-old man presented with left-sided jaw paresthesias, dysphagia and dysarthria. He was trialed on IVIG for 1.5 years without improvement and died 2.6 years after symptom onset. Conclusion: FOSMN is a rare disorder with a unique clinical and electrophysiological phenotype. The pathophysiology has been associated with neurodegeneration and multiple gene mutations have correlated to FOSMN. Some reports suggest transient response to immunomodulatory therapy, though prospective studies are lacking. CSF protein elevation may be seen in severe disease. Future studies will help further elucidate the approach to diagnosis, treatment, and prognostic counseling (biomarkers).  </jats:p>

dc.identifier.issn

2692-3092

dc.identifier.uri

https://hdl.handle.net/10161/28437

dc.publisher

The University of Kansas

dc.relation.ispartof

RRNMF Neuromuscular Journal

dc.relation.isversionof

10.17161/rrnmf.v4i2.18692

dc.title

Facial Onset Sensory and Motor Neuronopathy: A Case Series and Literature Review

dc.type

Journal article

duke.contributor.orcid

Morena, Jonathan|0000-0002-2952-0064

pubs.begin-page

34

pubs.end-page

42

pubs.issue

2

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Neurology

pubs.publication-status

Published online

pubs.volume

4

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12_RRNMF_4.2_Morena+et+al.pdf
Size:
404.11 KB
Format:
Adobe Portable Document Format